1. Home
  2. SCLX vs INTG Comparison

SCLX vs INTG Comparison

Compare SCLX & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$7.32

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Logo Intergroup Corporation (The)

INTG

Intergroup Corporation (The)

HOLD

Current Price

$37.90

Market Cap

59.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
INTG
Founded
2011
1965
Country
United States
United States
Employees
30
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
52.9M
59.3M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
SCLX
INTG
Price
$7.32
$37.90
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
28.1K
5.5K
Earning Date
04-06-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.46
Revenue
N/A
$74,753,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
N/A
P/E Ratio
N/A
$81.57
Revenue Growth
N/A
4.43
52 Week Low
$0.18
$10.37
52 Week High
$34.27
$42.50

Technical Indicators

Market Signals
Indicator
SCLX
INTG
Relative Strength Index (RSI) 37.25 65.15
Support Level $4.56 $25.16
Resistance Level $7.50 $41.75
Average True Range (ATR) 0.72 1.76
MACD 0.00 0.24
Stochastic Oscillator 4.62 83.23

Price Performance

Historical Comparison
SCLX
INTG

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About INTG Intergroup Corporation (The)

The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.

Share on Social Networks: